{"id":"W2091211366","doi":"10.1002/ibd.21870","title":"Recommendations for the treatment of Crohnʼs disease with tumor necrosis factor antagonists: An expert consensus report","year":2011,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Robarts Clinical Trials; Mount Sinai Hospital; Western University","funders":"Bristol-Myers Squibb Canada; Genentech; Celgene; AstraZeneca; Pfizer; Abbott Laboratories","keywords":"Infliximab; Medicine; Certolizumab pegol; Adalimumab; Crohn's disease; Inflammatory bowel disease; Internal medicine; Gastroenterology; Clinical trial; Tumor necrosis factor alpha; Surgery; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008147144,0.0003952223,0.0002383993,0.00006371088,0.0003416008,0.00004819042,0.0003225318,0.00007149334,0.0001689162],"category_scores_gemma":[0.0001284869,0.0002778052,0.0003064786,0.00005835638,0.0003988725,0.0000220901,0.00004510478,0.00003952581,0.000006080528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005513854,"about_ca_system_score_gemma":0.0006022518,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005238976,"about_ca_topic_score_gemma":0.0001180797,"domain_scores_codex":[0.9981371,0.0001124051,0.0005437912,0.0005997115,0.0002151736,0.0003918568],"domain_scores_gemma":[0.997422,0.00006408762,0.0003744757,0.001302763,0.0003159672,0.0005207374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0216466,0.004443402,0.9427814,0.0003061007,0.001345185,0.003430917,0.001906664,0.00007365511,0.009708103,0.0007578546,0.01094145,0.002658675],"study_design_scores_gemma":[0.002461404,0.0008657147,0.943682,0.00005196692,0.0004131603,0.0000439452,0.0007005134,0.0001252833,0.008698999,0.0001407684,0.04217863,0.0006376309],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944938,0.0007226795,0.0002485347,0.0001838747,0.0002604843,0.001449425,0.002466294,0.00007274035,0.0001021664],"genre_scores_gemma":[0.9959456,0.0002100668,0.000810553,0.0002761412,0.0003212778,0.001237548,0.000790012,0.00008917233,0.0003196172],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03123719,"threshold_uncertainty_score":0.9999674,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03020994861519771,"score_gpt":0.2766451697175737,"score_spread":0.246435221102376,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}